Are you looking for a meaningful next step in your career?

Welcome to your expert operating system for supply chain risk. Combining Tier-N transparency, supplier mapping, ESG standards, and due diligence compliance makes Prewave a unique software for supply chain management. Achieve resilience, transparency, and sustainability today 🇪🇺 ---- * Technical University of Vienna spin-off * TUW i2c incubated * Supported by AWS - Austria Wirtschaftsservice

Cell therapy has transformed cancer treatment, yet the hurdles of manufacturing patient-derived cell therapies remain a formidable challenge for the industry. Quality and scalability problems lead to high therapeutic costs and limit access to those life-saving treatments. By harnessing the power of cutting-edge semiconductor technologies, including silicon photonics seamlessly integrated into microfluidic cartridges, SARCURA is orchestrating a transformative shift. Central to SARCURA's mission is the creation of fully automated manufacturing systems endowed with real-time process and product control. This pioneering platform promises to usher in a new era of cost-effective and secure cell therapies, democratizing access to these critical treatments. We aim for a 100x production boost and 10x cost reduction, driving the industrialization of cell therapy manufacturing. Delve deeper at www.sarcura.com, where the future of cancer treatment is being reshaped.

Waste-to-X. We control bacteria to create power from waste. We believe in a world that uses all of its resources to achieve 100% renewable energy, which includes our waste. Our first 2 technologies have revolutionised the way the world is able to transform waste into energy.

We develop cutting-edge personalised neuromodulation technologies to solve the greatest challenges to brain health.

Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of patients are left without adequate treatment options - and AI trained with complex disease data can solve this.

Valanx Biotech develops a proprietary technology for site-specific protein conjugation for applications in therapeutics, diagnostics, and biocatalysis.

Tulon Photonics is a spin-off from the Institute of Science and Technology Austria (ISTA), specializing in tunable ultra-low noise lasers. These lasers are key for next-gen communication systems, remote sensing, and emerging quantum technologies. Fresh from an FFG spin-off fellowship, Tulon Photonics is now at the startup phase with disruptive technology, pushing forward to be at the forefront of photonics.

Vitrealab is a research and development company focusing on innovative photonic solutions for the lighting and display sector. By using glass-based waveguides, Vitrealab envisions revolutionary energy-efficient products.

Neurodevelopmental disorders are a huge unmet medical need with a high burden for patients and society. Neurolentech's vision is to become the world-leading company for patient-specific, molecularly defined cellular models in preclinical drug development for Autism, Epilepsy, and Intellectual Disability.

Cellectric is decoding the software of life. Our technology allows the continuous processing of cell suspensions while selectively permeabilizing or disintegrating targeted subsets by electromagnetic manipulation. Our competitive advantage is based on the exclusion of unspecific interference by a patented dielectric filter technology along our electrodes. The outcome features unrivaled specificity and throughput. Fast, automated, and selective.

Recatalyst is an EU-level recognized start-up company and Slovenian Start-up of the Year in 2023, which develops and markets services in the field of nanotechnology materials. The company is currently focused on the development and commercialization of next-gen platinum-based catalyst composites for use in hydrogen fuel cells and will expand its catalyst production platform also to other related areas for decarbonization of the energy and transport sectors such as water electrolysis as well as other power-to-X applications. The company has established development collaborations with some of the most reputable companies in the field in five of the G7 economies and is supported by the prestigious European EIC Transition financing, as well as a EUR 1.7M investment from international investors.

Rivus Batteries offers truly green batteries for stationary energy storage applications through organic flow batteries. Rivus technology is already proven on a small scale, currently looking for pilot customers interested in testing and pioneering sustainable stationary energy storage solutions in the size of 100 - 500 kWh.